Document is current
Any future updates will be listed below
-
Authors
Kataoka, Keiko https://orcid.org/0000-0002-8795-6536
Gale, Richard https://orcid.org/0000-0002-8847-044X
Li, Xiaoxin https://orcid.org/0000-0003-0536-2951
Şermet, Figen https://orcid.org/0000-0002-5834-7512
Qian, Cynthia X. https://orcid.org/0009-0004-3302-5754
Cheung, Chui Ming Gemmy https://orcid.org/0000-0003-3358-3516
Tsilimbaris, Miltiadis K. https://orcid.org/0000-0002-0130-1150
Kozak, Igor https://orcid.org/0000-0003-1813-0017
- License Information
-
More Information
Article History
Received: 16 September 2024
Revised: 5 December 2024
Accepted: 12 December 2024
First Online: 14 April 2025
Declarations
:
: This article does not report any studies involving human or animal participants performed by any of the authors.
: Keiko Kataoka received personal fees from Bayer, Boehringer Ingelheim, Canon MedTech, Chugai, OMC, Otsuka, Novartis, Santen, and Senju. Richard Gale is a consultant for AbbVie, Allergan, Apellis, Bayer, Biogen, Boehringer Ingelheim, Notal, Novartis, Roche, and Santen, and has received research grants from Bayer, Novartis, and Roche. Xiaoxin Li is a consultant for Kanghong, Novartis, and Ocumension, and has received research grants from Bayer. Figen Şermet is a consultant for AbbVie, Bayer, Novartis, Roche, and Thea. Cynthia X. Qian is a consultant for AbbVie, Apellis, Bayer, Boehringer Ingelheim, Novartis, and Roche. Chui Ming Gemmy Cheung has received consultant fees, speaker fees, and grant funding from Avirmax, Bayer, Boehringer Ingelheim, Iveric, Janssen, Novartis, Roche, Topcon, and Zeiss. Miltiadis K. Tsilimbaris has received personal fees from AbbVie, Bayer Hellas, Mavrogenis, and Novartis Hellas, and has received grants from Alcon, Bayer, Johnson & Johnson, and Novartis. Igor Kozak is a consultant for Alcon, Alimera, Allergan, Bayer, Roche, and Novartis.
